Summary
The outcome of breast cancer in an individual patient can be predicted by assessing a range of factors relating to the particular cancer. This assessment can be used to select treatments that are most likely to be successful, and to avoid futile or unnecessarily aggressive procedures.
Histopathological examination provides information on most of these factors. The most useful prognostic indicators in standard use are currently tumor stage, tumor grade, completeness of surgical excision, and estogen receptor status.
Key Words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fitzgibbons, P. L., Page, D. L., Weaver, D., et al. (2000) Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999. Arch. Pathol. Lab. Med. 124, 966–978.
Sobin, L. H. and Wittekind, C. H., eds. (2002) TNM Classification of Malignant Tumours, 6th Edition. Wiley-Liss, New York, NY.
Carter, C. L., Allen, C., and Hensen, D. E. (1989) Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63, 181–187.
Hensen, D. E., Ries, L., Freedman, L. S., and Carriaga, M. (1991) Relationship among outcome, stage of disease and histologic grade for 22,616 cases of breast cancer. Cancer 68, 2142–2149.
Veronesi, U., Galimberti, V., Zurrida, M., et al. (1993) Prognostic significance of number and level of axillary node metastases in breast cancer. Breast 2, 224–228.
National Coordinating Group for Breast Cancer Screening Pathology (2003) Pathology reporting in breast cancer screening. NHSBSP Publications, Sheffield, UK.
Weaver, D. L. (2003) Sentinel lymph nodes and breast carcinoma. Which micrometastases are clinically significant? Am. J. Surg. Pathol. 27, 842–845.
Pinder, S., Ellis, I. O., O’Rourke, S., et al. (1994) Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large series with long-term follow-up. Histopathology 24, 41–47.
Perrone, F., Carlomagno, C., Lauria, R., et al. (1996) Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? Eur. J. Cancer 32A, 41–46.
Elston, C. W. and Ellis, I. O. (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19, 403–410.
Pereira, H., Pinder, S. E., Sibbering, D., M., et al. (1995) Pathological prognostic factors in breast cancer IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27, 219–226.
Should aromatase inhibitors replace tamoxifen? (2003) Drug Ther. Bull. 41, 57–59.
Leake, R., Barnes, D., Pinder, S., et al. (2000) Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC. J. Clin. Pathol. 53, 634–635.
Singletary, S. E. (2002) Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am. J. Surg. 184, 383–393.
Jensen, R. A. and Page, D. L. (2003) Ductal carcinoma in situ of the breast. Impact of pathology on therapeutic decisions. Am. J. Surg. Pathol. 27, 828–831.
Mokbel, K. (2003) Towards optimal management of ductal carcinoma in situ of the breast. Eur. J. Surg. Oncol. 29, 191–197.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Roskell, D.E., Buley, I.D. (2006). Traditional and Established Indicators of Prognosis and Treatment Success. In: Brooks, S.A., Harris, A. (eds) Breast Cancer Research Protocols. Methods in Molecular Medicine, vol 120. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-969-9:79
Download citation
DOI: https://doi.org/10.1385/1-59259-969-9:79
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-191-2
Online ISBN: 978-1-59259-969-1
eBook Packages: Springer Protocols